Health
New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2 – News-Medical.Net
In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-C…
In a groundbreaking bioRxiv* study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – using both an S protein sequence optimized for cell surface expression and a conserved nucleocapsid antigen designed to be transported to the endosomal subcellular compartment.
In response to the ongoing health crisis brought by th…
-
Noosa News17 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General13 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News22 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News15 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia